Incidence, prevalence and survival of patients with rare epithelial digestive cancers diagnosed in Europe in 1995-2002

J. Faivre, A. Trama, R. De Angelis, M. Elferink, S. Siesling, R. Audisio, J. F. Bosset, A. Cervantes, C. Lepage

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Background and aims: Little is known about the epidemiology of rare epithelial digestive cancers. The aim of this study was to report on their incidence, prevalence and survival across Europe. Methods: The analysis was carried out on 50,646 cases diagnosed from 1995 to 2002 within a population of 162,000,000 in 21 European countries. Age-standardised incidence rates were computed using the European standard population. Prevalence rates, relative survival and period survival indicators for the years 2000-2002 were calculated. The expected number of new cases per year and of prevalent cases in Europe was estimated. Results: There were large variations in gallbladder epithelial cancer incidence rates: the incidence in Eastern Europe was 7 times higher than in the UK & Ireland. Differences between incidence rates were smaller for the other sites. The estimated number of new epithelial cancers arising in the EU each year was estimated to be 11,050 for extrahepatic bile duct cancer, 10,713 for gallbladder cancer, 5427 for anal cancer and 3595 for small intestine cancer. The corresponding estimated number of total prevalent cases was 18,483, 15,620, 40,589 and 13,276. There was also a large variation in the 5-year relative survival rate. For epithelial cancer of the anal canal, this varied between 66% (Central Europe) and 44% (Eastern Europe). The corresponding rates for small intestine cancers were 33% and 20%, for extrahepatic bile duct cancers, 17% and 12% and for gallbladder cancer 13% and 10%. Conclusion: There are large variations within Europe in the incidence and survival of rare digestive cancers according to geographic area.

Original languageEnglish
Pages (from-to)1417-1424
Number of pages8
JournalEuropean Journal of Cancer
Volume48
Issue number10
DOIs
Publication statusPublished - Jul 2012

Fingerprint

Gallbladder Neoplasms
Survival
Incidence
Bile Duct Neoplasms
Intestinal Neoplasms
Extrahepatic Bile Ducts
Eastern Europe
Neoplasms
Small Intestine
Survival Rate
Anus Neoplasms
Anal Canal
Ireland
Population
Epidemiology

Keywords

  • Anal canal
  • Cancer registries
  • Digestive cancer
  • Gallbladder and extra-hepatic bile duct cancer
  • Incidence
  • Prevalence
  • Rare diseases
  • Small intestine
  • Survival

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Incidence, prevalence and survival of patients with rare epithelial digestive cancers diagnosed in Europe in 1995-2002. / Faivre, J.; Trama, A.; De Angelis, R.; Elferink, M.; Siesling, S.; Audisio, R.; Bosset, J. F.; Cervantes, A.; Lepage, C.

In: European Journal of Cancer, Vol. 48, No. 10, 07.2012, p. 1417-1424.

Research output: Contribution to journalArticle

Faivre, J, Trama, A, De Angelis, R, Elferink, M, Siesling, S, Audisio, R, Bosset, JF, Cervantes, A & Lepage, C 2012, 'Incidence, prevalence and survival of patients with rare epithelial digestive cancers diagnosed in Europe in 1995-2002', European Journal of Cancer, vol. 48, no. 10, pp. 1417-1424. https://doi.org/10.1016/j.ejca.2011.10.038
Faivre, J. ; Trama, A. ; De Angelis, R. ; Elferink, M. ; Siesling, S. ; Audisio, R. ; Bosset, J. F. ; Cervantes, A. ; Lepage, C. / Incidence, prevalence and survival of patients with rare epithelial digestive cancers diagnosed in Europe in 1995-2002. In: European Journal of Cancer. 2012 ; Vol. 48, No. 10. pp. 1417-1424.
@article{afb1670c3eb64c2d9e86a78198287b19,
title = "Incidence, prevalence and survival of patients with rare epithelial digestive cancers diagnosed in Europe in 1995-2002",
abstract = "Background and aims: Little is known about the epidemiology of rare epithelial digestive cancers. The aim of this study was to report on their incidence, prevalence and survival across Europe. Methods: The analysis was carried out on 50,646 cases diagnosed from 1995 to 2002 within a population of 162,000,000 in 21 European countries. Age-standardised incidence rates were computed using the European standard population. Prevalence rates, relative survival and period survival indicators for the years 2000-2002 were calculated. The expected number of new cases per year and of prevalent cases in Europe was estimated. Results: There were large variations in gallbladder epithelial cancer incidence rates: the incidence in Eastern Europe was 7 times higher than in the UK & Ireland. Differences between incidence rates were smaller for the other sites. The estimated number of new epithelial cancers arising in the EU each year was estimated to be 11,050 for extrahepatic bile duct cancer, 10,713 for gallbladder cancer, 5427 for anal cancer and 3595 for small intestine cancer. The corresponding estimated number of total prevalent cases was 18,483, 15,620, 40,589 and 13,276. There was also a large variation in the 5-year relative survival rate. For epithelial cancer of the anal canal, this varied between 66{\%} (Central Europe) and 44{\%} (Eastern Europe). The corresponding rates for small intestine cancers were 33{\%} and 20{\%}, for extrahepatic bile duct cancers, 17{\%} and 12{\%} and for gallbladder cancer 13{\%} and 10{\%}. Conclusion: There are large variations within Europe in the incidence and survival of rare digestive cancers according to geographic area.",
keywords = "Anal canal, Cancer registries, Digestive cancer, Gallbladder and extra-hepatic bile duct cancer, Incidence, Prevalence, Rare diseases, Small intestine, Survival",
author = "J. Faivre and A. Trama and {De Angelis}, R. and M. Elferink and S. Siesling and R. Audisio and Bosset, {J. F.} and A. Cervantes and C. Lepage",
year = "2012",
month = "7",
doi = "10.1016/j.ejca.2011.10.038",
language = "English",
volume = "48",
pages = "1417--1424",
journal = "European Journal of Cancer",
issn = "0959-8049",
publisher = "Elsevier Ltd",
number = "10",

}

TY - JOUR

T1 - Incidence, prevalence and survival of patients with rare epithelial digestive cancers diagnosed in Europe in 1995-2002

AU - Faivre, J.

AU - Trama, A.

AU - De Angelis, R.

AU - Elferink, M.

AU - Siesling, S.

AU - Audisio, R.

AU - Bosset, J. F.

AU - Cervantes, A.

AU - Lepage, C.

PY - 2012/7

Y1 - 2012/7

N2 - Background and aims: Little is known about the epidemiology of rare epithelial digestive cancers. The aim of this study was to report on their incidence, prevalence and survival across Europe. Methods: The analysis was carried out on 50,646 cases diagnosed from 1995 to 2002 within a population of 162,000,000 in 21 European countries. Age-standardised incidence rates were computed using the European standard population. Prevalence rates, relative survival and period survival indicators for the years 2000-2002 were calculated. The expected number of new cases per year and of prevalent cases in Europe was estimated. Results: There were large variations in gallbladder epithelial cancer incidence rates: the incidence in Eastern Europe was 7 times higher than in the UK & Ireland. Differences between incidence rates were smaller for the other sites. The estimated number of new epithelial cancers arising in the EU each year was estimated to be 11,050 for extrahepatic bile duct cancer, 10,713 for gallbladder cancer, 5427 for anal cancer and 3595 for small intestine cancer. The corresponding estimated number of total prevalent cases was 18,483, 15,620, 40,589 and 13,276. There was also a large variation in the 5-year relative survival rate. For epithelial cancer of the anal canal, this varied between 66% (Central Europe) and 44% (Eastern Europe). The corresponding rates for small intestine cancers were 33% and 20%, for extrahepatic bile duct cancers, 17% and 12% and for gallbladder cancer 13% and 10%. Conclusion: There are large variations within Europe in the incidence and survival of rare digestive cancers according to geographic area.

AB - Background and aims: Little is known about the epidemiology of rare epithelial digestive cancers. The aim of this study was to report on their incidence, prevalence and survival across Europe. Methods: The analysis was carried out on 50,646 cases diagnosed from 1995 to 2002 within a population of 162,000,000 in 21 European countries. Age-standardised incidence rates were computed using the European standard population. Prevalence rates, relative survival and period survival indicators for the years 2000-2002 were calculated. The expected number of new cases per year and of prevalent cases in Europe was estimated. Results: There were large variations in gallbladder epithelial cancer incidence rates: the incidence in Eastern Europe was 7 times higher than in the UK & Ireland. Differences between incidence rates were smaller for the other sites. The estimated number of new epithelial cancers arising in the EU each year was estimated to be 11,050 for extrahepatic bile duct cancer, 10,713 for gallbladder cancer, 5427 for anal cancer and 3595 for small intestine cancer. The corresponding estimated number of total prevalent cases was 18,483, 15,620, 40,589 and 13,276. There was also a large variation in the 5-year relative survival rate. For epithelial cancer of the anal canal, this varied between 66% (Central Europe) and 44% (Eastern Europe). The corresponding rates for small intestine cancers were 33% and 20%, for extrahepatic bile duct cancers, 17% and 12% and for gallbladder cancer 13% and 10%. Conclusion: There are large variations within Europe in the incidence and survival of rare digestive cancers according to geographic area.

KW - Anal canal

KW - Cancer registries

KW - Digestive cancer

KW - Gallbladder and extra-hepatic bile duct cancer

KW - Incidence

KW - Prevalence

KW - Rare diseases

KW - Small intestine

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=84862014061&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862014061&partnerID=8YFLogxK

U2 - 10.1016/j.ejca.2011.10.038

DO - 10.1016/j.ejca.2011.10.038

M3 - Article

VL - 48

SP - 1417

EP - 1424

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

IS - 10

ER -